Marco Macagno

9PUBLICATIONS
89CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyLiquid biopsiesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 04, 2026
Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution.

|Nov 03, 2026
Calreticulin exposure is a critical mediator of high-dose vitamin C-induced immune surveillance in the tumor microenvironment.

|Nov 27, 2024
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection.

Marco Macagno, Valeria Pessei, Noemi Congiusta

|Jan 17, 2023
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.

Francesca Orzan, Francesca De Bacco, Elisabetta Lazzarini

|Sep 22, 2022
Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination.

Nadia Brasu, Ines Elia, Valentina Russo

|May 06, 2022
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.

Giovanni Crisafulli, Andrea Sartore-Bianchi, Luca Lazzari

Pageof 2

Frequent Collaborators

5 joint publications

Ludovic Barault

5 joint publications

Federica Di Nicolantonio

3 joint publications

Giovanni Crisafulli

2 joint publications

Federica Morano